[HTML][HTML] Sulodexide in the treatment of patients with early stages of COVID-19: a randomized controlled trial
AJ Gonzalez-Ochoa, JD Raffetto… - Thrombosis and …, 2021 - thieme-connect.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may induce several
vascular endothelial-dependent systemic complications, and sulodexide has pleiotropic …
vascular endothelial-dependent systemic complications, and sulodexide has pleiotropic …
Sulodexide in the Treatment of Patients with Early Stages of COVID-19: A Randomized Controlled Trial
AJ Gonzalez-Ochoa, JD Raffetto, AG Hernández… - 2021 - pubmed.ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may induce several
vascular endothelial-dependent systemic complications, and sulodexide has pleiotropic …
vascular endothelial-dependent systemic complications, and sulodexide has pleiotropic …
[PDF][PDF] Sulodexide in the treatment of patients with early stages of COVID-19: a randomised controlled trial
AJ Gonzalez-Ochoa, JD Raffetto, AG Hernández… - scholar.archive.org
Background Targeting endothelial cells has been suggested for the treatment of patients
with COVID-19 and sulodexide has pleiotropic properties within the vascular endothelium …
with COVID-19 and sulodexide has pleiotropic properties within the vascular endothelium …
[HTML][HTML] Sulodexide in the treatment of patients with early stages of COVID-19: a randomised controlled trial
AJ Gonzalez-Ochoa, JD Raffetto, AG Hernández… - 2020 - europepmc.org
Background Targeting endothelial cells has been suggested for the treatment of patients
with COVID-19 and sulodexide has pleiotropic properties within the vascular endothelium …
with COVID-19 and sulodexide has pleiotropic properties within the vascular endothelium …
Sulodexide in the Treatment of Patients with Early Stages of COVID-19: A Randomized Controlled Trial
AJ Gonzalez-Ochoa, JD Raffetto… - Thrombosis and …, 2021 - thieme-connect.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may induce several
vascular endothelial-dependent systemic complications, and sulodexide has pleiotropic …
vascular endothelial-dependent systemic complications, and sulodexide has pleiotropic …
Sulodexide in the treatment of patients with early stages of COVID-19: a randomised controlled trial
AJG Ochoa, JD Raffetto, NA Zavala, O Gutierrez… - 2020 - pesquisa.bvsalud.org
BackgroundTargeting endothelial cells has been suggested for the treatment of patients with
COVID-19 and sulodexide has pleiotropic properties within the vascular endothelium that …
COVID-19 and sulodexide has pleiotropic properties within the vascular endothelium that …
Sulodexide in the treatment of patients with early stages of COVID-19: a randomised controlled trial
AJ Gonzalez-Ochoa, JD Raffetto, AG Hernández… - medRxiv, 2020 - medrxiv.org
Background Targeting endothelial cells has been suggested for the treatment of patients
with COVID-19 and sulodexide has pleiotropic properties within the vascular endothelium …
with COVID-19 and sulodexide has pleiotropic properties within the vascular endothelium …
Sulodexide in the Treatment of Patients with Early Stages of COVID-19: A Randomized Controlled Trial.
AJ Gonzalez-Ochoa, JD Raffetto… - Thrombosis and …, 2021 - europepmc.org
Sulodexide in the Treatment of Patients with Early Stages of COVID-19: A Randomized
Controlled Trial. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …
Controlled Trial. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …